0.612
前日終値:
$0.623
開ける:
$0.6101
24時間の取引高:
220.08K
Relative Volume:
0.23
時価総額:
$32.67M
収益:
-
当期純損益:
$-151.16M
株価収益率:
-0.2061
EPS:
-2.97
ネットキャッシュフロー:
$-130.08M
1週間 パフォーマンス:
-14.67%
1か月 パフォーマンス:
-44.36%
6か月 パフォーマンス:
-67.10%
1年 パフォーマンス:
-94.45%
Alx Oncology Holdings Inc Stock (ALXO) Company Profile
名前
Alx Oncology Holdings Inc
セクター
電話
650-466-7125
住所
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
ALXO を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ALXO
Alx Oncology Holdings Inc
|
0.612 | 32.67M | 0 | -151.16M | -130.08M | -2.97 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.74 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
617.00 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
567.09 | 34.59B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
255.76 | 33.10B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
271.04 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-03-06 | アップグレード | Jefferies | Hold → Buy |
2024-12-19 | ダウングレード | Jefferies | Buy → Hold |
2024-03-08 | ダウングレード | Stifel | Buy → Hold |
2023-12-08 | アップグレード | Jefferies | Hold → Buy |
2021-12-22 | ダウングレード | Jefferies | Buy → Hold |
2021-09-30 | 開始されました | Stifel | Buy |
2021-05-05 | 再開されました | Credit Suisse | Outperform |
2021-04-26 | 再開されました | Credit Suisse | Outperform |
2021-04-06 | 開始されました | UBS | Buy |
2021-02-10 | 開始されました | H.C. Wainwright | Buy |
2020-08-11 | 開始されました | Cantor Fitzgerald | Overweight |
2020-08-11 | 開始されました | Credit Suisse | Outperform |
2020-08-11 | 開始されました | Jefferies | Buy |
2020-08-11 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Alx Oncology Holdings Inc (ALXO) 最新ニュース
ALXO stock touches 52-week low at $0.65 amid market challenges - Investing.com
Cantor Fitzgerald Raises Earnings Estimates for ALX Oncology - Defense World
ALXO stock plunges to 52-week low of $0.73 amid market challenges - Investing.com Australia
ALXO stock plunges to 52-week low of $0.73 amid market challenges By Investing.com - Investing.com South Africa
ALX Oncology Holdings (ALXO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Why ALX Oncology Holdings Inc. (ALXO) Soared on Thursday - MSN
ALXO stock touches 52-week low at $0.89 amid market challenges - Investing.com Australia
ALXO stock touches 52-week low at $0.89 amid market challenges By Investing.com - Investing.com South Africa
Insider Buying: Rekha Hemrajani Acquires 30,000 Shares of ALX On - GuruFocus.com
ALX Oncology Holdings: Balancing Growth Potential and Uncertainty with a Hold Rating - TipRanks
Stifel Nicolaus Lowers ALX Oncology (NASDAQ:ALXO) Price Target to $1.50 - Defense World
ALX Oncology (NASDAQ:ALXO) Earns “Buy” Rating from HC Wainwright - Defense World
Why the Global Cancer Market Could Surpass $900 Billion-And the Stocks Leading the Charge - The Malaysian Reserve
Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge - PR Newswire
Sun Valley buying at Canagold Resources (CCM) - The Globe and Mail
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Jefferies Financial Group Upgrades ALX Oncology (NASDAQ:ALXO) to “Buy” - Defense World
Stifel cuts ALX Oncology stock target to $1.50, maintains hold By Investing.com - Investing.com Canada
Promising Developments in ALX Oncology’s Clinical Pipeline Justify Buy Rating - TipRanks
Jefferies raises ALX Oncology stock to buy, target to $3 By Investing.com - Investing.com South Africa
ALX Oncology Reports 2024 Financial Results and Updates - TipRanks
Micro-, Small-Cap Firms Dominate Market Rally - Insider Monkey
Alx Oncology Holdings Inc Files For Mixed Shelf Of Up To $364.1 Million -March 06, 2025 at 05:35 pm EST - Marketscreener.com
ALX Oncology Holdings Inc (ALXO) Q4 2024 Earnings: EPS of -$0.55 Beats Estimate, Revenue Matches Forecast - GuruFocus.com
ALX Oncology Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ALX Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - The Manila Times
ALX Oncology Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
ALX Oncology jumps as Jefferies upgrades on upside potential - MSN
ALX Oncology stock jumps as Jefferies upgrades(ALXO:NASDAQ) - Seeking Alpha
This Zscaler Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga India
ALX Oncology to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Barchart
ALX Oncology Cuts 30% Workforce, Eliminates President And CSO Role Amid Pipeline Prioritization - Nasdaq
Jefferies Upgrades ALX Oncology to Buy From Hold, Adjusts Price Target to $3 From $2 - Marketscreener.com
Jefferies Upgrades ALX Oncology Holdings (ALXO) - Nasdaq
ALX Oncology Holdings: Undervalued with Promising Catalysts and Growth Opportunities - TipRanks
Jefferies raises ALX Oncology stock to buy, target to $3 - Investing.com
ALX Oncology announces workforce reduction and officer departure By Investing.com - Investing.com Australia
ALX Oncology announces workforce reduction and officer departure - Investing.com India
ALX Oncology Announces Workforce Reduction and Leadership Change - TipRanks
ALX Oncology to Cut Workforce by 30% to Support New Clinical Initiatives -March 05, 2025 at 11:04 am EST - Marketscreener.com
ALX Oncology Highlights Focused Evorpacept Development - GlobeNewswire
ALX Oncology Highlights Focused Evorpacept Development Plan, Clinical Progress and Corporate Updates at R&D Day Webcast Event - Yahoo Finance
ALXO stock plunges to 52-week low, touches $0.96 By Investing.com - Investing.com South Africa
ALXO stock plunges to 52-week low, touches $0.96 - Investing.com
ALX Oncology (ALXO) to Release Earnings on Thursday - MarketBeat
When Will ALX Oncology Share Its 2024 Financial Performance? Key Date for Biotech Investors - StockTitan
ALX Oncology (ALXO) Projected to Post Earnings on Thursday - Defense World
H.C. Wainwright cuts ALX Oncology target to $5, keeps buy rating - MSN
Alx Oncology Holdings Inc (ALXO) 財務データ
収益
当期純利益
現金流量
EPS
Alx Oncology Holdings Inc (ALXO) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Pons Jaume | PRESIDENT & CSO |
Feb 19 '25 |
Sale |
1.15 |
1,326 |
1,525 |
579,388 |
Lettmann Jason | CHIEF EXECUTIVE OFFICER |
Feb 19 '25 |
Sale |
1.15 |
2,159 |
2,483 |
170,270 |
Pinto Shelly | Interim CFO |
Jan 06 '25 |
Sale |
1.80 |
2,221 |
3,998 |
87,902 |
Pinto Shelly | Interim CFO |
Dec 30 '24 |
Sale |
1.58 |
1,426 |
2,253 |
90,123 |
Pons Jaume | PRESIDENT & CSO |
Dec 30 '24 |
Sale |
1.58 |
10,796 |
17,060 |
580,714 |
Hemrajani Rekha | Director |
Dec 02 '24 |
Buy |
1.55 |
30,000 |
46,404 |
33,000 |
Pinto Shelly | SVP, FINANCE AND CAO |
Aug 14 '24 |
Sale |
2.58 |
564 |
1,455 |
91,549 |
Randolph Sophia | CHIEF MEDICAL OFFICER |
Aug 14 '24 |
Sale |
2.58 |
1,365 |
3,522 |
325,711 |
Pons Jaume | PRESIDENT & CSO |
Aug 14 '24 |
Sale |
2.58 |
1,937 |
4,997 |
591,510 |
Pons Jaume | PRESIDENT & CSO |
Jul 11 '24 |
Option Exercise |
0.99 |
20,000 |
19,800 |
613,447 |
大文字化:
|
ボリューム (24 時間):